Our Services > Real World Evidence Solutions

RWE Advisory Services

Advisory Services: Expert Support for Life Sciences and Healthcare Product Lifecycle

Maxis Clinical Sciences offers a suite of Comprehensive Advisory Services under RWE, designed to guide biopharma, life sciences and healthcare organizations through every stage of the product lifecycle.

Our approach combines in-depth industry knowledge with advanced analytics, offering insights that drive both clinical and commercial success. From inception to new indications and optimized delivery, our services ensure maximized product value and strategic market positioning.

Core Advisory Services

Product Lifecycle Management

We provide end-to-end support, encompassing product conception, new indications, and optimized delivery through healthcare distribution channels.

Real World Evidence Studies

Our expertise in RWE studies includes identifying the right real-world data (RWD) for hypothesis testing, retrospective, prospective, and epidemiological studies.

Health Economics and Outcomes Research (HEOR) & Market Access

We focus on identifying clinically relevant patient outcomes to enhance patient health and maximize market access…

Regulatory and Safety Compliance

Utilizing RWD, we ensure regulatory compliance, track safety, and manage adverse events through active and passive surveillance.

Launch Support

Leveraging RWE, we augment the evidence package to highlight product value and competitive advantage during peri-launch activities.

Molecule Acquisition and Drug Development Partnerships

We guide in identifying and evaluating target molecules and potential partners for co-development alliances.

Revenue Management

Implementing data-driven strategies to optimize revenue streams, considering market conditions and regulatory compliance…
Read More

Mergers and Acquisitions Support

Offering comprehensive support for M&A activities, including strategy development, due diligence, negotiations, and integration.

Clinical Pathway Optimization

Utilizing RWE to refine clinical pathways, ensuring treatments are both effective and aligned with current best practices, to improve patient outcomes and healthcare efficiency.